相关实验视频
Updated: May 7, 2026

10:53
Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
5.4K
基于机器学习的对患有多变性心肌病的患者心血管结果的歧视
Tae-Min Rhee1,2, Yeon-Kyoung Ko3,4, Hyung-Kwan Kim1
1Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
JACC. Asia
|May 20, 2024
概括
机器学习模型可以准确地预测高性心肌病 (HCM) 患者的主要心血管事件. 左心房直径和高血压是关键预测因素,比传统方法更能改善风险分层.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 数据科学数据科学数据科学
背景情况:
- 传统的高性心肌病 (HCM) 风险分层有局限性.
- 需要新的方法来改善患者的治疗结果.
研究的目的:
- 开发和验证机器学习 (ML) 模型,用于预测HCM患者的主要不良心血管事件 (MACE).
- 确定影响HCM心血管风险的关键临床和心声学特征.
主要方法:
- 利用了2,111名HCM患者的数据,分析了25个临床和心声学特征.
- 开发了四个ML模型,通过交叉验证 (AUROC) 选择了性能最好的后勤回归模型.
- 采用了SHapley添加式扩展 (SHAP) 来确定MACE的特征重要性,所有原因的死亡,心力衰竭入院和中风.
主要成果:
- 后勤回归模型显示了MACE (AUROC=0.800) 和其组件的强有力的预测性能.
- 外部验证证实了该模型对MACE (AUROC=0.768),全因死亡 (AUROC=0.750) 和HF-adm (AUROC=0.806) 的辨别能力.
- 在SHAP分析中,左心脏直径和高血压被确定为所有不良结果的显著预测因素.
结论:
- ML模型有效地区分HCM患者的心血管事件.
- 这些模型为关键风险因素提供了有价值的见解,增强了当前的风险分层策略.
- 左心脏直径和高血压是预测HCM不良结果的关键变量.
相关概念视频
Cardiomyopathy I: Introduction and Classification
837
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762

